Related Experiment Video
Updated: Jul 9, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy
Jens-Uwe Stolzenburg1, Robert Rabenalt, Minh Do
1Department of Urology, University of Leipzig, Leipzig, Germany. stolj@medizin.uni-leipzig.de
European Urology
|December 18, 2007
Summary
The intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy (nsEERPE) refines prostatectomy by preserving nerves. This technique demonstrates high rates of continence and potency, advocating for its viability in preserving neurovascular bundles.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Radical prostatectomy is a primary treatment for prostate cancer.
- Preservation of neurovascular bundles is crucial for functional outcomes.
- Endoscopic extraperitoneal radical prostatectomy (EERPE) offers a minimally invasive approach.
Purpose of the Study:
- To present the refined intrafascial nerve-sparing EERPE (nsEERPE) technique.
- To evaluate the functional outcomes (continence and potency) and oncological results of nsEERPE.
Main Methods:
- The intrafascial technique involves dissection directly on the prostatic capsule.
- Preservation of the puboprostatic ligament, endopelvic fascia, periprostatic fascia, and neurovascular bundles.
- The procedure was performed on 150 patients indicated for nerve-sparing surgery.
Main Results:
- Mean operative time was 131 minutes; mean catheterization time was 5.9 days.
- Postoperative continence at 12 months was 94.3%; potency rates varied by age group (89.7% for 44-55 yrs, 81.1% for 56-65 yrs, 61.9% for >65 yrs).
- Positive surgical margins were 4.5% for pT2 and 29.4% for pT3 tumors.
Conclusions:
- Intrafascial nsEERPE allows prostate dissection with minimal trauma to surrounding structures.
- The technique preserves neurovascular bundles, potentially enhancing their viability.
- Results support the efficacy of intrafascial nsEERPE for functional and oncological outcomes.
